Indeed, TENM3 down-regulation, compared to normal tissues, has been observed in several tumors, including brain lower grade glioma, adrenocortical, colon, rectum, and uterine corpus endometrial carcinomas (Figure 4). The gene discussed is TENM3; the disease is central nervous system cancer.